 |
|
| Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
| Reply |
|
|
Thread Tools | Display Modes |
02-03-2011, 10:57 AM
|
#1 | ||
|
|||
|
Member
|
Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease
SAN DIEGO, Feb. 3, 2011 /PRNewswire " To date, approximately 20 percent of the 52 subjects have undergone either CERE-120 administration or sham surgery, with many others enrolled and awaiting surgery. It is anticipated that enrollment will be completed near the end of June 2011." " 'It is encouraging that CERE-120 continues to appear safe and that the new dosing paradigm we implemented seems well-tolerated,' stated Joao Siffert, M.D., Ceregene's vice president, chief medical officer." |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Diseas | Parkinson's Disease | |||
| MJFF Funds Continuing Analysis of Data from Phase 2 Trial of CERE-120 | Parkinson's Disease | |||
| CERE-120 /May2009/ Clinical Data from Phase 2 Trial of CERE-120 for PD | Parkinson's Disease Clinical Trials | |||
| CERE-120 phase II trial results - shocking | Parkinson's Disease | |||
| CERE-120 Phase II trials fall of 2006 | Parkinson's Disease | |||
Update Phase 2b CERE-120
Linear Mode
